USAGE OF T-CELL RECEPTOR BETA-CHAIN VARIABLE GENE IS HIGHLY RESTRICTED AT THE SITE OF INFLAMMATION IN MURINE AUTOIMMUNE UVEITIS JOURNAL OF IMMUNOLOGY Rao, N. A., Naidu, Y. M., Bell, R., Lindsey, J. W., Pararajasegaram, G., Sun, Y. M., Steinman, L. 1993; 150 (12): 5716-5721

Abstract

Improved molecular methods allow identification of the specific autoaggressive T cells involved in autoimmune inflammations. In this study of interphotoreceptor retinoid-binding protein-induced uveitis, TCR V beta usage was studied using RNA-polymerase chain reaction amplification of transcripts derived directly from ocular tissues and from T cell lines obtained from the spleen. Specific V beta 5' primers from the major murine TCR V beta families were coupled with a common 3' primer from the V beta C region. Amplification of rearranged TCR V beta-D beta-J beta-C beta sequences was confirmed by Southern blot analysis. In ocular tissue from sensitized mice, TCR V beta expression was limited mainly to one to three V beta families, with predominant expression of V beta 2, V beta 12, and V beta 15. In most animals there was similar, albeit limited, TCR gene usage in both the recognition of autoantigen in uveitogenic T cell lines and at the site of inflammation in the eye. Identification of a limited TCR V beta repertoire in Ag-reactive T cell lines correlated with TCR usage at the target site of autoimmune expression. The gene products of the restricted TCR V beta rearrangements found in lesions and in the cell lines may serve as the target for selective immunotherapy.

View details for Web of Science ID A1993LH97800052

View details for PubMedID 8390540